Information Provided By:
Fly News Breaks for April 25, 2017
PKI, BRKR, WAT
Apr 25, 2017 | 12:52 EDT
Cantor Fitzgerald analyst Bryan Brokmeier raised his price target for Waters (WAT) to $190 citing the company's "strong" Q1 results. Consensus estimates continue under-appreciate the strength in Biopharma, the analyst tells investors in a post-earnings research note. He keeps an Overweight rating on Waters. Brokmeier views the company's earnings report as mixed for peers Bruker (BRKR) and PerkinElmer (PKI).
News For WAT;BRKR;PKI From the Last 2 Days
There are no results for your query WAT;BRKR;PKI